Keyphrases
Patients with Cancer
100%
Melphalan
100%
Cytokine Production
100%
Tumor Necrosis Factor-α
100%
Circulating T Cells
100%
T Cells
60%
Interferon-γ
60%
Isolated Limb Perfusion
60%
Interleukin-4 (IL-4)
60%
Th1 Cells
40%
Th2 Cells
40%
T Helper 1
40%
Cell-derived
20%
Cancer Patients
20%
T Cell Subpopulations
20%
Interleukin-2
20%
Cell-to-cell
20%
Cellular Level
20%
Tolerability
20%
Systemic Circulation
20%
T Cell Activation
20%
Th1-Th2
20%
Ionomycin
20%
Monoclonal Antibody
20%
Cell Culture Model
20%
Intracytoplasmic
20%
T Helper 2
20%
Anti-CD28
20%
Anti-CD3
20%
Phorbol 12-myristate 13-acetate
20%
Blood Cell Cultures
20%
Selective Effect
20%
Whole Blood Cells
20%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Melphalan
100%
Cytokine
100%
Tumor Necrosis
100%
Gamma Interferon
60%
Limb Perfusion
60%
Interleukin 4
60%
Tolerability
20%
Cell Culture
20%
Tumor Necrosis Factor
20%
Systemic Circulation
20%
Interleukin 2
20%
12-O-Tetradecanoylphorbol-13-Acetate
20%
Monoclonal Antibody CD28
20%
Ionomycin
20%
CD3 Antigen
20%
Nursing and Health Professions
Melphalan
100%
Tumor Necrosis
100%
Limb Perfusion
60%
Interleukin 4
60%
Gamma Interferon
60%
Malignant Neoplasm
20%
Interleukin 2
20%
Tumor Necrosis Factor
20%
Cell Culture
20%
Monoclonal Antibody CD28
20%
Flow Cytometer
20%
Ionomycin
20%
Cell Level
20%
Phorbol 13 Acetate 12 Myristate
20%
CD3 Antigen
20%
Veterinary Science and Veterinary Medicine
T Cell
100%
Limb Perfusion
30%
Hemocyte
10%